ABOUT SIRPIGLENASTAT CLINICAL TRIAL

“This distinct prodrug design and style created DON focused to its supposed destination (tumor) and possess much less of the effect on wholesome cells somewhere else.”It has anticancer effects by specifically focusing on tumor metabolism and simultaneously inducing a powerful antitumor immune response with immunomodulatory and antineoplastic th